SERA PROGNOSTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SERA PROGNOSTICS, INC. (SERA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 663.23 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 663.23K shares, a 31.48% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 107.00K shares.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 888.96K shares, a 953.37% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 84.39K shares, a 91.49% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 991.87K shares, a 70.19% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.33M shares, a 20.71% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 663.23K shares 10-Q · filed 2026-08-12 | 770.23K shares derived: sum of 3 quarters · filed 2026-08-12 | 770.23K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 663.23K shares 10-Q · filed 2026-05-06 | 770.23K shares derived: sum of 2 quarters · filed 2026-05-06 | 770.23K shares derived: sum of 3 quarters · filed 2026-05-06 | 1.05M shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 107.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 107.00K shares derived: sum of 2 quarters · filed 2026-03-18 | 384.53K shares derived: sum of 3 quarters · filed 2026-03-18 | 888.96K shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 277.53K shares derived: sum of 2 quarters · filed 2025-11-13 | 781.96K shares 10-Q · filed 2025-11-13 | 781.96K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 277.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 781.96K shares 10-Q · filed 2025-08-06 | 781.96K shares derived: sum of 3 quarters · filed 2025-08-06 | 792.51K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 504.42K shares 10-Q · filed 2025-05-07 | 504.42K shares derived: sum of 2 quarters · filed 2025-05-07 | 514.97K shares derived: sum of 3 quarters · filed 2025-05-07 | 588.82K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 10.55K shares derived: sum of 2 quarters · filed 2025-03-19 | 84.39K shares derived: sum of 3 quarters · filed 2025-03-19 | 84.39K shares 10-K · filed 2025-03-19 |
| 2024-09-30 | 10.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 84.39K shares derived: sum of 2 quarters · filed 2024-11-06 | 84.39K shares 10-Q · filed 2024-11-06 | 84.39K shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 73.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 73.84K shares 10-Q · filed 2024-08-07 | 73.84K shares derived: sum of 3 quarters · filed 2024-08-07 | 73.84K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-08 | 0.00 shares derived: sum of 3 quarters · filed 2024-05-08 | 379.59K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-20 | 379.59K shares derived: sum of 3 quarters · filed 2024-03-20 | 991.87K shares 10-K · filed 2024-03-20 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 379.59K shares derived: sum of 2 quarters · filed 2023-11-08 | 991.87K shares 10-Q · filed 2023-11-08 | 1.13M shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 379.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 991.87K shares 10-Q · filed 2023-08-09 | 1.13M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.23M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 612.28K shares 10-Q · filed 2023-05-10 | 754.28K shares derived: sum of 2 quarters · filed 2023-05-10 | 852.28K shares derived: sum of 3 quarters · filed 2023-05-10 | 2.02M shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 142.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 240.00K shares derived: sum of 2 quarters · filed 2023-03-22 | 1.41M shares derived: sum of 3 quarters · filed 2023-03-22 | 3.33M shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 98.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 1.27M shares derived: sum of 2 quarters · filed 2022-11-09 | 3.19M shares 10-Q · filed 2022-11-09 | 3.55M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 1.17M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 3.09M shares 10-Q · filed 2022-08-10 | 3.45M shares derived: sum of 3 quarters · filed 2022-08-10 | 3.96M shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 1.92M shares 10-Q · filed 2022-05-10 | 2.28M shares derived: sum of 2 quarters · filed 2022-05-10 | 2.79M shares derived: sum of 3 quarters · filed 2022-05-10 | |
| 2021-12-31 | 360.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 871.16K shares derived: sum of 2 quarters · filed 2022-03-29 | 2.76M shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | 510.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 2.40M shares 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 1.89M shares 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |